A hybrid differential and spatially resolved spectroscopy (SRS) technique has been developed to measure absolute absorption coefficient (µ a ), reduced scattering coefficient (µ s ) and cerebral blood volume (CBV) in the adult human head. A spectrometer with both differential and SRS capabilities has been used to carry out measurements in 12 subjects. Two versions of the calculation have been considered using the hybrid technique, with one considering water as a chromophore as well as oxy-and deoxy-haemoglobin, and one ignoring water. The CBV has also been measured using a previously described technique based on changing the arterial saturation (SaO 2 ) measured separately by a pulse oximeter, resulting in mean ± SD CBV a (intra-individual coefficient of variation) = 2.22 ± 1.06 ml/100 g (29.9%). 
Abstract
A hybrid differential and spatially resolved spectroscopy (SRS) technique has been developed to measure absolute absorption coefficient (µ a ), reduced scattering coefficient (µ s ) and cerebral blood volume (CBV) in the adult human head. A spectrometer with both differential and SRS capabilities has been used to carry out measurements in 12 subjects. Two versions of the calculation have been considered using the hybrid technique, with one considering water as a chromophore as well as oxy-and deoxy-haemoglobin, and one ignoring water. The CBV has also been measured using a previously described technique based on changing the arterial saturation (SaO 2 ) measured separately by a pulse oximeter, resulting in mean ± SD CBV a (intra-individual coefficient of variation) = 2.22 ± 1.06 ml/100 g (29.9%). (The superscript on CBV indicates the different calculation basis.) Using the hybrid technique with water ignored, CBV 0 = 3.18 ± 0.73 ml/100 g (10.0%), µ 
Introduction
It has been demonstrated that absolute optical properties such as the absorption (µ a ) and reduced scattering coefficients (µ s ) of human tissues including the head, calf, arm, skin and muscle can be measured using near-infrared (NIR) phase, time or spatially resolved spectroscopy (SRS) systems (Farrell et al 1992 , Duncan et al 1995 , Matcher et al 1997 , Gratton et al 1997 , Doornbos et al 1999 . While a continuous-wave system using differential spectroscopy (DS) and a single source-detector spacing can only measure changes of µ a , i.e. µ a , the absolute µ a cannot be easily measured because of the unknown scattering and geometry dependent losses that occur in the complex tissue geometry in which measurements are made (Delpy and Cope 1997) . Subsequently, changes in oxy-and deoxy-haemoglobin concentrations can only be calculated as changes from arbitrary baseline values, i.e. [ HbO 2 ] and [ HHb] . It has been shown that a SRS-based technique can be used to calculate a scaled absolute µ a , i.e. µ s µ a where µ s is considered as a time-invariant scaling factor (Matcher et al 1995 , Suzuki et al 1999 . The NIRO-300 (Hamamatsu Photonics KK) is a commercial spectrometer with both DS and SRS capabilities originally designed to measure changes in haemoglobin concentrations using the measured µ a and a tissue oxygenation index (TOI) using the scaled absolute µ a . The TOI has been used as a measure to monitor average cerebral oxygenation in various research areas such as obstructive sleep apnoea (Valipour et al 2002) , liver transplant (Panzera et al 2005) and premature infants (Naulaers et al 2002) . This paper suggests a way to use the NIRO-300 as a platform to estimate absolute µ a and µ s in the human forehead by combining both µ a (calculated from the DS data) and µ s µ a (calculated from the SRS data) measurements. Since both DS and SRS data have been used, this technique is referred to as a hybrid DS and SRS technique. The absolute total haemoglobin concentration, [HbT] , and hence cerebral blood volume (CBV) can also be calculated in the process. The hybrid technique discussed here requires the underlying µ a to vary within a physiologically limited range while µ s remains relatively unchanged. Such alterations in µ a can be achieved by a variety of physiological manoeuvres but in the example reported here are induced by brief hypoxic swings where the fraction of inspired oxygen (FiO 2 ) is lowered within a small range. During a brief hypoxic episode, arterial oxygen saturation (SaO 2 ) drops and [ HbO 2 ] decreases while [ HHb] increases; this physiological phenomenon causes a variation in µ a . Studies have been conducted on 12 adult subjects in which the FiO 2 has been altered. Another aim of this study was to use and to compare two versions of the hybrid DS-SRS technique (where one version takes into account the background water absorption and the other does not) during controlled changes in FiO 2 to estimate absolute µ a and µ s and hence calculate CBV. Finally, we have compared the estimates of CBV made using the hybrid technique with those using a previous technique based on the SaO 2 as measured by a pulse oximeter (Wyatt et al 1990 , Elwell et al 1994 , Gupta et al 1997 , Wolf et al 2002 in terms of bias and coefficient of variation.
Methodology

Experiment and instrumentation
Twelve healthy volunteers of mean ± SD age 32 ± 4 years participated in the studies in which three consecutive graded arterial hypoxaemias were carried out. The study protocol was approved by the local ethics committee and all subjects gave informed consent for participation. A commercial NIR monitor (NIRO-300, Hamamatsu Photonics KK) with both DS and SRS capabilities was used to measure attenuation parameters, including A(λ) at four wavelengths (775, 813, 853 and 910 nm) and ∂A(λ)/∂ρ at three wavelengths (775, 813 and 853 nm), at a sampling rate of 6 Hz. The optodes were placed on the forehead (taking care to avoid the midline sinuses) and were shielded from ambient light by using an elastic bandage and a black cloth. The studies took place in a darkened room. An optode spacing of 4 cm was used. A modified anaesthetics trolley supplied a controlled mixture of nitrogen and oxygen to the subject via a face mask. Arterial saturation was monitored from the ear with a pulse oximeter (Novametrix 500) modified to measure in a beat-to-beat mode. FiO 2 was monitored continuously with a multi-parameter patient monitor (Merlin, Hewlett Packard). All measurements were made with the volunteers sitting comfortably in an armchair. The subject initially breathed normal air for 3-5 min. The FiO 2 in the circuit was then gradually reduced to 11-15% by mixing air and nitrogen, until a baseline SaO 2 of 90% was achieved. At that point, the subject was given 100% O 2 for five consecutive breaths followed by a return to breathing air. This sequence was repeated for a total of three times for each subject. Figure 1 shows an example of data collected during the experiment. Three hypoxic episodes can be seen with SaO 2 never reaching below 90%. The de-saturation of SaO 2 to 90% is not expected to cause a significant change in cerebral blood flow or oxygen consumption which may affect the validity of the proposed method. A significant rise in cerebral blood flow only occurs when SaO 2 falls below ∼75% (Wyatt et al 1990 , Johannssen and Siesjo 1975 , Kogure et al 1970 . Previous animal and human studies have also shown that slight arterial hypoxaemia causes no change in global cerebral oxygen consumption (Johannssen and Siesjo 1975, Siesjo 1978) .
Estimation of absorption and reduced scattering coefficients
Based on the modified Beer-Lambert law, the difference between µ a at two time points, i.e. µ a , can be calculated from a measurement of the difference of attenuation at those time points ( A):
where ρ is the optode spacing, DPF is the differential pathlength factor, A and C are column vectors containing attenuation changes and concentration changes, respectively, and ε is a matrix consisting of the specific absorption coefficients of chromophores at specified wavelengths. The superscript 'DS' signifies the association with differential spectroscopy. When A is measured with the log base of 10, the scaling factor ln 10 needs to be introduced to convert equation (1) to the log base of e with which µ a is defined in the diffusion equation.
With µ DS a measured at two or more wavelengths, preferably with at least one on each side of the isobestic point at 800 nm, [ HbO 2 ] and [ HHb] can be calculated by the least-square fit (Cope 1991) . Four wavelengths at 775, 813, 853 and 910 nm have been used here.
Based on the semi-infinite half-space geometry, the solution of the diffusion equation for light transport in tissue in a continuous-wave system can be differentiated with respect to the optode spacing ρ, resulting in an expression for µ SRS a scaled by µ s (Matcher et al 1995) :
where ∂A/∂ρ is the attenuation slope measured with multiple detectors and has a log base of 10. To emphasize the significance of the wavelength dependence of µ a and µ s , these values are expressed as functions of λ, i.e. µ a (λ) and µ s (λ) in this section. While the wavelength dependence of µ a (λ) is a function of all the chromophores' concentrations in the field of view, the wavelength dependence of µ s (λ) in tissues has been found to remain relatively linear. One widely used form of wavelength dependence of µ s (λ) is formulated as µ s (λ) = aλ −b , where constants a and b have been estimated experimentally in breast tissue and pig blood (Cerussi et al 2001 , Durduran et al 2002 , Srinivasan et al 2005 . Matcher et al measured the wavelength dependence of µ s (λ) in human heads and used a different formulation µ s (λ) = k(aλ + b), where a = −6.5 × 10 −4 mm −1 nm −1 , b = 1.45 mm −1 and k can be considered as a constant in the NIR region (Matcher et al 1997) . It should be noted that both formulations result in a µ s (λ) which decreases mainly linearly with increasing wavelength in the NIR range. In this paper, we use the latter formulation which is based on measurements on the human head. The linear behaviour of µ s (λ) simplifies its estimation at other wavelengths because once µ s (λ * ) has been estimated at one wavelength (i.e. λ * ) its values at other wavelengths (i.e. λ) can be approximated by
where q(λ * ) = 1. Equation (2) can now be rewritten as
Equation (4) is similar to an equation in Suzuki et al (1999) except here µ SRS a (λ) is scaled by µ s (λ * ) rather than k. In the following, we consider three wavelengths, say λ 1 , λ 2 , λ 3 and we choose λ * = λ 1 . The scaled chromophore concentrations can now be estimated by a least-square fit:
where j = λ 1 , λ 2 , λ 3 and C is a column vector containing absolute chromophore concentrations. Equation (5) shows that using µ s (λ)µ SRS a (λ) calculated from the attenuation slope (∂A(λ)/∂ρ), the product of µ s (λ) and the absolute concentrations can be obtained. We will use the superscripts '0' (water ignored) and 'w' (water considered) to distinguish how the chromophore concentrations are calculated. We consider C and ε i,j in two cases. In the first case, C = (Cope 1991 , Sevick et al 1991 . The inclusion of water in the conventional least-square fit, i.e. pseudo inverse, often leads to erroneous negative values of absolute water concentrations. A least-square algorithm with non-negativity constraints has been used here to perform the conversion (Lawson and Hanson 1974 (5) can be expressed as It is also worth mentioning that an alternative approach of estimating µ s (λ 1 ) from µ DS a (λ 1 ) of equation (1) and (4) is to fit a straight line between these two measurements and the gradient is then µ s (λ 1 ) (Leung et al 2003) . Using this approach, µ s (λ 1 ) is estimated by the use of two attenuation measurements, namely A(λ 1 ) and ∂A(λ 1 )/∂ρ at the same wavelength. However, the results obtained from this alternative approach are more susceptible to noise compared to that described here. This is because instead of two raw measurements, the technique introduced here makes use of seven attenuation measurements, namely A(λ) at four wavelengths and ∂A(λ)/∂ρ at three wavelengths, which tends to reduce the effects of noise. × 100% (7) and is calculated from the attenuation measurements ∂A(λ)/∂ρ via equations (4) and (5) In a situation whereby FiO 2 is carefully adjusted while keeping the CBV, CBF and oxygen consumption relatively constant, [ HbO 2 ] and TOI will both change in proportion and their relationship can be expressed as
Estimation of cerebral blood volume with tissue oxygenation index
where TOI is either TOI 0 or TOI w and we again assume [ HbO 2 ] ≈ − [ HHb] . As shown in figure 3, which will be discussed further in section 2.4, values of [ HbD] and TOI 0 are plotted against each other during a hypoxic episode. A straight line can be found by performing total least squares on the data points and its gradient is [HbT] as suggested by equation (8). This approach is very similar to an earlier technique based on arterial saturation (SaO 2 ) measured from a pulse oximeter (Wyatt et al 1990 , Elwell et al 1994 , Gupta et al 1997 , Wolf et al 2002 , except TOI instead of SaO 2 has been used here. The [HbT] and hence CBV estimated using SaO 2 has also been calculated for comparison in the following analysis.
Data selection
In sections 2.2 and 2.3, we propose the use of total least squares to estimate µ s (λ 1 ) from equation (6) and [HbT] from equation (8), via the gradients of regressed lines. Strictly speaking, the linear nature of this approach makes it valid only when the underlying parameter, i.e. either µ s (λ 1 ) or [HbT] , stays constant during a hypoxic manoeuvre. In reality, we can tolerate moderate variations of the underlying µ s (λ 1 ) or [HbT] . The value of µ s (λ 1 ) is normally quite stable over time unless there is a large change of the number of scatterers in the tissues, which could be caused by a large change in the number of red blood cells or blood volume. Therefore, the stability of [HbT] can in a way reflect that of µ s (λ 1 ) and we will focus on the variation of [HbT] in the following discussion. Figure 4 corresponding data points are to be included in the estimation of [HbT] , the accuracy of the result will be affected because equation (8) is not always valid for all the data points. The strategy adopted here is to only include data points whose corresponding [ HbT] vary within certain defined limits of the mean level of [ HbT] , which have been set to ±0.5 µM (determined from experience) in this work for adult subjects. In other words, we only select data points for analysis when equation (8) using only the selected data points. In figure 3 , a total least squares has been performed on [ HbD] and TOI 0 to estimate [HbT] . In this case, [HbT] = 61.3 µM without any selection of data points and [HbT] = 72.5 µM using only the selected data points.
One way to check the applicability of equation (8) is to consider the correlation coefficient between [ HbD] and TOI. The correlation coefficient of the selected data points is as high as 0.87 in the example given in figure 3 indicating a good reliability of the results. From experience, a correlation coefficient smaller than 0.8 is taken to indicate a potential violation of assumptions behind equation (8) and the corresponding data points are considered unsuitable for the estimation of [HbT] and µ s (λ 1 ).
Conversion from the absolute haemoglobin concentration to the cerebral blood volume
Blood consists of both haemoglobins and plasma but [HbT] only accounts for haemoglobin concentration in tissues. To convert [HbT] into CBV, we need to divide [HbT] by the average haemoglobin concentration in the cerebral blood but this cannot easily be measured non-invasively. Instead, the haemoglobin concentration in blood is measured from the peripheral circulation and the average cerebral haemoglobin concentration estimated using the cerebral large-to-small vessel haematocrit ratio (CLVHR). This ratio accounts for the reduced red cell content of blood in the cerebral vessels compared to that in the large venous vessels (due to the Fahraeus effect) from which the blood sample has been taken (Wyatt et al 1990) . The following formula has been used for the conversion:
where MW Hb = 64 500 g is the molecular weight of haemoglobin, d t = 1.05 g ml −1 is the cerebral tissue density (Nelson et al 1971) , Hb t (g dl −1 ) is the haemoglobin concentration obtained from a venous sample and CLVHR = 0.69 (Lammertsma et al 1984) . Equation (9) has been used in previous studies to convert [HbT] into CBV (Wyatt et al 1990 , Elwell et al 1994 , Gupta et al 1997 , Wolf et al 2002 , Leung et al 2004 . A variation of the formula has also been employed in a CBV study using indocyanine green as the tracer (Hopton et al 1999) .
Data analysis
In the following analysis, the differential pathlength factor (DPF) was determined by an equation accounting for the age dependence: DPF(780 nm) = 5.13 + 0.07AGE 0.81 , where AGE = 32 (mean age of the subjects). In this study, all subjects were in the same age group and one differential pathlength factor value of 6.3 (calculated using the mean age) was used for all analyses. This equation is based on a study of 283 subjects whose age ranges from 1 day to 50 years (Duncan et al 1996) . In order to remove cardiac-related and spontaneous oscillations (Elwell et al 1999 , Obrig et al 2000 , respectively, for each hypoxic episode. In the data selection, only those data points corresponding to a [ HbT] of less than ±0.5 µM were included in the analysis. Once µ s (λ) has been estimated, µ a (λ) at 775, 813 and 853 nm can also be estimated at 6 Hz (the sampling rate). Averaged µ a (λ) was then calculated over 20 s of a normoxic period when subjects were breathing room air. Using the approaches discussed in sections 2.3-2.5, three sets of [HbT] and CBV were calculated for each hypoxic episode, respectively, which used (a) TOI 0 , (b) TOI w and (c) SaO 2 . For the first two TOI-based methods, both the de-saturation and the re-saturation periods were used. Since SaO 2 was measured at the ear lobes and [ HbD] was measured at the forehead, there was a time delay between these signals. This delay was manually corrected for in the data before further analysis was performed. In the SaO 2 method, the linear regression method (instead of the total least squares method) has been used to calculate [HbT] = [ HbD]/(2 SaO 2 ) following the practice in previous studies (Wyatt et al 1990 , Elwell et al 1994 , Gupta et al 1997 .
Results
Cerebral blood volume
The correlation coefficient between [ HbD] and TOI/SaO 2 during a hypoxic episode was used to assess whether there was sufficient linear relationship between these two parameters and hence whether the resulting CBV measurement was valid. A total of 36 hypoxic episodes from 12 subjects (three hypoxaemias from each subject) were recorded in this study. Using (a) CBV 0 and CBV a ; bias = 0.79 ± 1.22 ml/100 g; (b) CBV w and CBV a ; bias = 0.65 ± 1.24 ml/100 g; (c) CBV 0 and CBV w ; bias = 0.14 ± 0.09 ml/100 g. a threshold of 0.8 for the correlation coefficient, 27 measurements from 10 subjects were considered valid for the calculation of both CBV 0 (using TOI 0 with water ignored) and CBV w (using TOI w with water considered), and 21 measurements from 9 subjects were valid for the calculation of CBV a (using SaO 2 ). The excluded hypoxic episodes were considered to be affected by movement artefacts or by changes of the other monitored physiological parameters. In one subject, none of the data achieved the required threshold, and so the whole data set was excluded from the analysis. The mean ± SD CBV using the three approaches were CBV 0 = 3.18 ± 0.73 ml/100 g, CBV w = 3.05 ± 0.77 ml/100 g and CBV a = 2.22 ± 1.06 ml/100 g. In order to assess the repeatability of each analysis method, CBV results from subjects having three valid hypoxic episodes were used to calculate the intra-individual coefficients of variation. These were 10.0% for CBV 0 (n = 9), 10.5% for CBV w (n = 8) and 29.9% CBV a (n = 4). The degrees of agreement using the three analysis methods were analysed using a BlandAltman analysis (Bland and Altman 1986) . Out of a total of 36 hypoxic episodes, 20 from eight subjects were considered valid for CBV estimations using all three analysis methods. The rest of the hypoxic measurements were deemed invalid in one or more analysis methods. The biases (mean difference ± SD) calculated from the Bland-Altman plots in figure 5 are summarized in table 1.
Absorption and reduced scattering coefficients
The means and standard deviations of µ s (λ) and µ a (λ) calculated using the [ HbD 0 ] (with water ignored) and [ HbD w ] (with water considered) are summarized in table 2. As discussed in section 2.2, µ s (λ) at one wavelength was estimated from a hypoxic measurement and µ s (λ) at the other two wavelengths were simply calculated by scaling using equation (3). Therefore, 
Bias between the
Mean difference ± two methods standard deviation (ml/100 g) CBV 0 and CBV w 0.14 ± 0.09 CBV 0 and CBV a 0.79 ± 1.22 CBV w and CBV a 0.65 ± 1.24 Table 2 . Mean and standard deviation of µ s and µ a at λ = 775, 813 and 853 nm estimated using the hybrid technique with and without taking water into consideration (n = 27). the coefficient of variation of µ s (λ) calculated from three hypoxic measurements was the same for all the three wavelengths. As for µ a (λ), the coefficient of variation was also the same for the three wavelengths. This was because firstly the same resting period had been used for the calculation of an averaged µ a (λ) in the three hypoxic measurements and secondly the 
Discussion and conclusions
We have developed a hybrid DS and SRS technique to calculate µ s , µ a and CBV in the adult head. This work extends the functionality of a type of NIRS systems based on the SRS principle (e.g. NIRO-300, NIRO-200 and NIRO-100, Hamamatsu Photonics KK). Two versions of the same calculation have been discussed, namely one considering water (resulting in µ The mean CBVs calculated from the three methods (i.e. CBV 0 = 3.18 ± 0.73 ml/100 g, CBV w = 3.05 ± 0.77 ml/100 g and CBV a = 2.22 ± 1.06 ml/100 g) are comparable to the published results in one study of 2.85 ± 0.97 ml/100 g for adults (Elwell et al 1994) . To find the gradient between SaO 2 and [ HbD], previous CBV studies have performed linear regression which only accounts for errors in the y-axis only, i.e. [ HbD] (Wyatt et al 1990 , Elwell et al 1994 . In one CBV study, a scheme was proposed to minimize errors in both SaO 2 and [ HbD] which is based on a function of averaging the gradients of two regressed lines, i.e. regressing SaO 2 on [ HbD] and regressing [ HbD] on SaO 2 (Wolf et al 1997) . In the current study, a more straightforward technique known as total least squares (Van Huffel and Vanderwalle 1991), which minimize the perpendicular distances between data points and the regressed line, has been used. The gradients and hence CBV (i.e. CBV 0 and CBV w ) estimated using total least squares tend to be higher than those obtained using linear regression (i.e. CBV a ), as evident from our results. Other NIR-based studies of CBV in the literature have reported a range of different results. While one study based on SaO 2 reported a higher value of CBV of 5.38 ml/100 g (Gupta et al 1997) , another study using ICG as the tracer reported a lower value of 1.1 ± 0.39 ml/100 g (Hopton et al 1999) . The discrepancies could be due to the use of different instruments, differential pathlength factors and tracers. In a SPECT study, a CBV of 4.81 ± 0.37 ml/100 g has been reported for regional brain tissues (Sakai et al 1985) .
As an imaging technique, the SPECT result contains data only from the brain tissue whereas NIR systems probe all the tissues between the optodes including scalp, skull and brain, resulting in an averaged tissue blood volume, which may be lower than that of the brain alone. Out of 36 hypoxic episodes, the hybrid technique has resulted in a higher number of valid CBV measurements of 27, compared to the SaO 2 -based technique which had 21. The robustness of the hybrid technique is further demonstrated by its intra-individual coefficients of variation of 10.0% (water ignored) and 10.5% (water considered), compared to the SaO 2 -based technique value of 29.9%. The lack of robustness of the SaO 2 -based technique is not a surprise considering that the technique involves two separate instruments, namely a pulse oximeter and a tissue spectrometer, and also requiring the manual synchronization of their signals. In comparison, the hybrid technique is more direct and simple and only one spectrometer with DS and SRS capabilities is needed.
It is theoretically more 'correct' to consider water in the calculation. However, the mean difference and especially the SD between CBV 0 and CBV w are small (0.14 ± 0.09 ml/100 g), showing that CBV 0 can be used in place of CBV w with only moderate differences (CBV 0 is higher than CBV w by approximately 4.6%). The hybrid technique including water requires an iterative least-square algorithm with non-negativity constraints which increases the intraindividual coefficient of variation slightly because an additional concentration (water) is also estimated. The algorithm is also more computationally expensive than the simple arithmetic operations required by the hybrid technique with the water ignored. The SDs of differences between CBV 0 and CBV a (1.22 ml/100 g) and between CBV w and CBV a (1.24 ml/100 g) are both large showing that the degree of agreement between the hybrid techniques and the SaO 2 -based technique is limited.
The mean µ s and µ a at the three wavelengths (775, 813 and 853 nm) with water considered are very close to those with water ignored. The mean µ 0 s (813 nm) = 1.19 ± 0.55 mm −1 is comparable to the previously published result of µ s (800 nm) = 0.94 ± 0.07 mm −1 using a time-resolved system (Matcher et al 1997) , while the mean µ 0 a (813 nm) = 0.010 ± 0.003 mm −1 is lower than that obtained in the same time-resolved study µ a (800 nm) = 0.016 ± 0.001 mm −1 . The SDs of both µ s (813 nm) and µ a (813 nm) are comparatively larger than those obtained using a time-resolved system. The intra-individual coefficients of variation of µ by approximately 6% with a mean difference of (5.9 ± 10.0) × 10 −4 mm −1 at 813 nm. One has to be careful when it comes to the interpretation of µ s , µ a and CBV estimated here. First, as mentioned earlier, in the calculation of µ s , µ a and CBV, a pre-defined constant known as the differential pathlength factor is required. Depending on the location of the measurement site and the age of the subject, the differential pathlength factor can vary from 5.13 in infants to 6.26 in adults (Duncan et al 1996) . It has also been reported that the differential pathlength factor has a standard deviation of approximately 15% among the same group of subjects which also affects the accuracy of the estimates of µ s , µ a and CBV. By adding a pathlength measuring capability to the existing SRS system (whether through the use of phase or time based measurement), the differential pathlength factor could be measured for individual subjects and hence improve the accuracy of the estimated µ s , µ a and CBV. Second, the technique assumes the tissues to be homogenous rather than layered and inhomogeneous as is found in reality. The estimated µ s , µ a and blood volume are therefore averaged values for all tissues in the field of view including the skin, skull, cerebrospinal fluid and brain, rather than just for a specific layer such as the brain. Third, in the conversion from [HbT] to CBV, the scaling factor known as the cerebral to large vessel haematocrit ratio is used to compensate for the reduced red cell content of blood in cerebral vessels compared to that in the large vessels due to the Fahraeus effect. The exact value of this scaling factor is still a subject of controversy with values ranging from the 0.69 used here (Lammertsma et al 1984) to 0.75 (Sakai et al 1985) .
The continuous-wave system used in this study employs simple and economical optoelectronic devices compared to its frequency/time domain counterparts which require frequency modulation or photon counting. The frequency/time domain systems can however measure the differential pathlength directly and do not rely on a pre-set differential pathlength factor, resulting in more accurate results.
